Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile
KCO and performance status are the strongest independent predictors of survival in LC-ILD. AREs are frequent and highly lethal. Dedicated therapeutic guidelines and an adapted ILD-GAP-cancer prognostic tool are urgently needed. Beyond clinical parameters our findings suggest a distinct molecular landscape dominated by TP53, KRAS and PI3K pathway alteration.
Authors
- M. Reynaud-Gaubert
- E. Pollien
- M. Barboni
- A. Goga
- J. Milesi
- J. Pluvy
- P. Tomasini
- G. Soussi
- J. Bermudez
- L. Greillier
- P. Habert
- E. Gouton
- A. Fourdrain
- A. Mogenet
- R. Naud
- B. Coiffard
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Fondation FondaMental (FR)
- Hôpital Nord (FR)
- Centre de Recherche en Cancérologie de Marseille (FR)
Publication Details
- Journal
- Lung Cancer
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1016/j.lungcan.2026.109379
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00